Crohn-betegség: vizsgálatok itt: Ausztrália
20 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Where
- Adelaide, Brisbane, Clayton, Concord, Melbourne
- Életkor
- 16 év to 80 év
- People
- 1200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00 - 3. fázisTaking peopleA Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
- Where
- Nedlands, Parkville, South Brisbane
- Életkor
- 2 év to 17 év
- People
- 100 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07298421 · EU 2025-523318-96-00 - 2. fázisTaking peopleA Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Where
- Bedford Park, Elizabeth Vale, Herston, Kurralta Park, Melbourne, Perth, Woolloongabba, QLD
- Életkor
- 18 év to 85 év
- People
- 385 worldwide
- Run by
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
See details and how to joinNCT06226883 · EU 2023-508158-24-00 - No phaseTaking peopleSpecific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study
- Where
- Hobart, Melbourne, Sydney
- Életkor
- 18 év and over
- People
- 50
- Run by
- Austin Health
See details and how to joinNCT07916727 - 3. fázisTaking peopleA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Where
- Nedlands, South Brisbane, Westmead
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05923073 · EU 2023-504735-41-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Nedlands, South Brisbane, Westmead
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 2/3. fázisTaking peopleA Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Adelaide, Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, South Brisbane
- Életkor
- 18 év and over
- People
- 1092 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07196722 · EU 2025-521382-27-00 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Adelaide, Camperdown, Clayton, Kurraba Point, Macquarie Island, Murdoch, New Lambton, South Brisbane, West Melbourne
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577843 · EU 2026-525922-39-00 - 2. fázisTaking peopleA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Where
- Bedford Park, Concord, Epping, Footscray, Murdoch, Nedlands, Perth, South Brisbane, Woodville
- Életkor
- 18 év to 75 év
- People
- 268 worldwide
- Run by
- Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Where
- Brisbane, Footscray, Kurralta Park
- Életkor
- 18 év to 75 év
- People
- 99 worldwide
- Run by
- Sanofi
See details and how to joinNCT06958536 · EU 2024-517016-30-00 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Adelaide, Footscray, Mackay, Macquarie Park, Parkville, Wahroonga
- Életkor
- 16 év to 80 év
- People
- 425 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06819891 · EU 2024-513054-30-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Birtinya, Clayton, Liverpool, Nedlands, South Brisbane, Southport, Wollongong
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184931 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Salzburg, South Brisbane, Vienna
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184944 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Adelaide, Epping, Garran, Herston, Murdoch, Perth, South Brisbane, Sydney, Woolloongabba
- Életkor
- 16 év to 80 év
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00 - 3. fázisTaking peopleA Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Clayton, Parkville, South Brisbane, Westmead
- Életkor
- 2 év to 17 év
- People
- 240 worldwide
- Run by
- Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00 - 3. fázisTaking peopleA Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Where
- Clayton, Parkville, South Brisbane, Westmead
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Takeda
See details and how to joinNCT04779320 · EU 2023-509045-13-00 - 4. fázisTaking peopleVECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Where
- Adelaide, Concord, Epping, Heidelberg, Melbourne, Murdoch, South Brisbane, Woodville
- Életkor
- 18 év to 80 év
- People
- 304 worldwide
- Run by
- Alimentiv Inc.
See details and how to joinNCT06257706 · EU 2023-509096-16-00 - No phaseNot yet taking people in AusztráliaUse of Water Ingestion in Small Intestine Ultrasound
- Where
- Heidelberg
- Életkor
- 18 év to 80 év
- People
- 55
- Run by
- Austin Health
See details and how to joinNCT07079007 - 1/2. fázisTaking peopleMicrobial Restoration in Inflammatory Bowel Diseases
- Where
- Melbourne
- Életkor
- 18 év to 70 év
- People
- 120
- Run by
- St Vincent's Hospital Melbourne
See details and how to joinNCT04970446 - No phaseTaking peopleThe ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
- Where
- Melbourne
- Életkor
- 18 év to 80 év
- People
- 13
- Run by
- Austin Health
See details and how to joinNCT05469607